We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Adjuvant Treatment of Concurrent RT and CAPOX or Capecitabine Alone for Stage II and III Rectal Cancer

This study is currently recruiting participants.
Verified February 2016 by Jing Jin, M.D., Chinese Academy of Medical Sciences
Sponsor:
ClinicalTrials.gov Identifier:
NCT00714077
First Posted: July 14, 2008
Last Update Posted: February 17, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Collaborators:
Zhejiang Cancer Hospital
Cancer Hospital of Guizhou Province
Shandong Cancer Hospital and Institute
Hebei Medical University Fourth Hospital
Peking University Third Hospital
General Hospital of Chinese Armed Police Forces
Beijing Hospital
Information provided by (Responsible Party):
Jing Jin, M.D., Chinese Academy of Medical Sciences
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2018
  Estimated Primary Completion Date: January 2018 (Final data collection date for primary outcome measure)